Ildong Pharmaceutical Reports 17.8 Billion KRW Operating Loss in 4Q... Deficit Widens
[Asia Economy Reporter Han Jinju] Ildong Pharmaceutical announced on the 17th that its preliminary earnings for the fourth quarter of last year showed an operating loss of 17.8 billion KRW, a 203.9% increase in the deficit compared to the same period last year. During the same period, sales increased by 2.8% to 142.4 billion KRW, and the net loss widened by 388.5% to 93.1 billion KRW.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- One in 77 Koreans Exposed to Drugs... Enough Money for 6,600 Luxury Gangnam Apartments Circulates in Drug Market [ChwiYakGukga] ⑩
- "Greater Impact on Women Than Men"... The 'Diet Trap' That Causes Sleepless Nights and Suffering
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
